Literature DB >> 5706389

Alpha-methyl-p-tyrosine in the symptomatic treatment of patients with malignant phaeochromocytoma.

K Pyörälä, E Pitkänen, S Toivonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5706389

Source DB:  PubMed          Journal:  Ann Med Intern Fenn        ISSN： 0365-4362


× No keyword cloud information.
  3 in total

1.  Malignant pheochromocytoma. Effect of oral alpha-methyl-p-tyrosine upon catecholamine metabolism.

Authors:  J H Hengstmann; R Gugler; H J Dengler
Journal:  Klin Wochenschr       Date:  1979-04-01

Review 2.  alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

3.  The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.

Authors:  Lucinda M Gruber; Sina Jasim; Allison Ducharme-Smith; Toby Weingarten; William F Young; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.